AdvertisementNew antiviral drugs are coming for COVID. Here's what you need to knowUpdated November 30, 2021Pien HuangfacebookEmailMolnupiravir, an antiviral drug to treat mild to moderate COVID-19, is under consideration by the FDA for possible authorization. (Merck)This article was originally published on November 30, 2021.
